Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma

This publication has 25 references indexed in Scilit:

• Diagnostic Performance of Whole Body Dual Modality ¹⁸F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients
  Journal of Clinical Oncology, 2006
• Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma
  European Journal Of Cancer, 2006
• High-Resolution Whole-Body Magnetic Resonance Image Tumor Staging With the Use of Parallel Imaging Versus Dual-Modality Positron Emission Tomography–Computed Tomography
  Investigative Radiology, 2005
• Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography
  European Journal of Radiology, 2005
• Fast Whole-Body Assessment of Metastatic Disease Using a Novel Magnetic Resonance Imaging System
  Investigative Radiology, 2005
• Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PET
  Journal of Clinical Oncology, 2004
• A Role for FDG-PET in the Surgical Management of Stage IV Melanoma
  Annals of Surgical Oncology, 2004
• A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy
  Annals of Surgical Oncology, 2004
• The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision Making
  Clinical Nuclear Medicine, 2003
• Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival?
  Annals of Surgical Oncology, 2001